News Category
Regentis Biomaterials is progressing its GelrinC cartilage regeneration implant through clinical trials, FDA submission preparation, and European comm...
Quantum BioPharma advances a two-pronged approach to neurological health, combining its investigational MS therapy Lucid-MS with its supplement unbuzz...
Quantum BioPharma is advancing a two-pronged approach to neurological health, targeting myelin repair in multiple sclerosis with Lucid-MS and addressi...
VERAXA Biotech's proprietary BiTAC platform and pipeline of next-generation antibody therapeutics position it for potential partnerships and licensing...
VERAXA Biotech has advanced its VXA-222 bispecific ADC program past the discovery phase and expanded its patent portfolio, underscoring its progress i...
A novel liquid biopsy offers a simpler method to predict which advanced lung cancer patients will respond to immunotherapy, potentially improving trea...
GeoVax announces completion of manufacturing, regulatory, clinical, and preclinical milestones for its GEO-MVA mpox/smallpox vaccine, positioning it f...
Onco-Innovations is combining PNKP-targeted DDR inhibition, nanoparticle delivery, and causal AI to accelerate cancer drug development, with lead cand...
Nagoya University researchers discovered that the immune protein C3, when produced within tumors, can make them more susceptible to immunotherapy, pot...
VolitionRx's new Capture-Seq technology achieves >99% pure ctDNA isolation, potentially transforming cancer detection and monitoring, with a combined ...
Tonix Pharmaceuticals announced its participation in two key investor conferences, highlighting its ongoing efforts to engage with the investment comm...
VERAXA Biotech has advanced its VXA-222 bispecific antibody-drug conjugate into the next development stage and expanded its patent portfolio, strength...
NeuroThera Labs has initiated its Phase IIb clinical trial at Yale Child Study Center, advancing a potential new cannabinoid-based treatment for Toure...
SRX Global's investment in Vistagen Therapeutics underscores its strategy to unlock value in undervalued biopharmaceutical assets, potentially influen...
SRX Global's acquisition of a stake in Vistagen highlights its strategy of investing in undervalued high-conviction companies and engaging with manage...
Quantum BioPharma's pilot MS imaging study with Massachusetts General Hospital has reached its enrollment midpoint with promising preliminary data, po...
Biotech Labz Supply Inc now offers 11 high-purity research peptides, including BPC-157 and Tesamorelin, all backed by batch-specific certificate of an...
Oncotelic Therapeutics is set to present at the OTCQB Virtual Investor Conference, showcasing progress in its Phase 1b trial, platform validation, and...
Tonix Pharmaceuticals announced FDA feedback supporting its adaptive Phase 2 field study of TNX-4800, a long-acting monoclonal antibody for Lyme disea...
Recent independent findings suggest cross-reactive immune responses among ebolaviruses, reinforcing the strategic importance of GeoVax's multi-antigen...
Regentis Biomaterials is advancing GelrinC, a potentially first-in-class, off-the-shelf cartilage regeneration platform, addressing a major unmet need...
Quantum BioPharma's pilot MS imaging study with Massachusetts General Hospital shows promising early results, potentially enhancing the development of...
NeuroThera Labs announced its quantum platform successfully processed real-world clinical data through a full hybrid quantum-classical analytical work...
NeuroOne released a white paper on its StereoCED platform, which aims to address scalability challenges in brain drug delivery by enabling simultaneou...
VERAXA Biotech strengthens scientific leadership with a new CSO as it advances its proprietary BiTAC® platform toward clinical development, positionin...
Onco-Innovations Limited closed a CAD$5 million private placement with Sorbie Bornholm LP and Sorbie Investments LLP, providing funding to advance its...
Lexaria Bioscience Corp. announces a 1-for-15 reverse stock split effective August 3, 2026, to increase its share price above the Nasdaq minimum $1.00...
VolitionRx Limited announces that multiple peer-reviewed studies confirm its Nu.Q H3.1 test can distinguish sepsis from non-infectious inflammation, c...
Instinct Bio announces a strategic collaboration with INVITRX to expand its GENREVER cosmetic line into the U.S. and support regenerative medicine ini...
Renaissance BioScience Corp. appoints Dr. James Tansey, a seasoned entrepreneur and academic, to its board to support growth and commercialization of ...
Dr. Sven K. Weber, former BASF Vice President, will become CEO of BRAIN Biotech AG on October 1, 2026, as Adriaan Moelker retires after six years of r...
VERAXA Biotech has expanded its patent portfolio with new filings covering its BiTAC-TCE and BiTAC-ADC platforms, strengthening protection through 204...
MindBio Therapeutics has completed and delivered its first Edge AI Intoxication and Fatigue Detection Kiosk prototypes, aiming to provide rapid, scala...
VERAXA Biotech strengthens its scientific leadership with the appointment of Dr. Christoph Erkel as Chief Scientific Officer, positioning the company ...
VERAXA Biotech AG announced the expansion of its intellectual property portfolio with new patent applications covering its BiTAC-TCE and BiTAC-ADC pla...
Greenland Mines (GRML) obtained a Canadian patent for Klotho-based gene therapies targeting neurodegenerative diseases, expanding its IP portfolio and...
Quantum BioPharma's executive outlines the development strategy for Lucid-MS, a potential multiple sclerosis treatment, and highlights the commercial ...
VERAXA Biotech shareholders approved corporate governance and financing measures with over 99.94% support, enabling greater flexibility for acquisitio...
Greenland Mines Ltd. has been granted a Canadian patent for Klotho-based gene therapies, expanding its IP portfolio and advancing treatments for Alzhe...
NanoViricides has submitted an application to begin a Phase II trial of its oral antiviral NV-387 for the Bundibugyo ebolavirus strain, which currentl...
The EMA clearance for Lantern Pharma’s biomarker-guided Phase 1b/2 trial of LP-184 in advanced bladder cancer marks a key step in advancing AI-driven ...
GeoVax Labs reports Q2 2026 financial results, advancing its GEO-MVA vaccine candidate toward a pivotal immunobridging study under an expedited regula...
VERAXA Biotech announced the advancement of its bispecific ADC program VXA-222 after OmniAb completed a key technical milestone, moving the program in...
Quantum BioPharma's executive discusses the company's dual strategy of advancing Lucid-MS for multiple sclerosis through a Phase 2 trial and commercia...
Onco-Innovations is progressing its lead PNKP inhibitor ONC010, with advancements in kilogram-scale manufacturing, drug delivery partnerships, and cli...
Tonix Pharmaceuticals will report Q2 2026 financial results and operational highlights on Aug. 10, 2026, with a conference call and webcast to discuss...
VERAXA Biotech announced the advancement of its bispecific antibody-drug conjugate program VXA-222 after OmniAb completed discovery work, moving the p...
Onco-Innovations combines a novel PNKP inhibitor with nanoparticle delivery and AI-driven trial design to address resistance, trial failures, and drug...
